Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
117TH CONGRESS
1ST SESSION H. R. 1176
To amend title XXVII of the Public Health Service Act to require group
health plans and health insurance issuers offering group or individual
health insurance coverage to provide coverage for prostate cancer
screenings without the imposition of cost-sharing requirements, and for
other purposes.
IN THE HOUSE OF REPRESENTATIVES
FEBRUARY 18, 2021
Mr. RUSH (for himself and Mr. BUCSHON) introduced the following bill; which
was referred to the Committee on Energy and Commerce
A BILL
To amend title XXVII of the Public Health Service Act
to require group health plans and health insurance
issuers offering group or individual health insurance cov-
erage to provide coverage for prostate cancer screenings
without the imposition of cost-sharing requirements, and
for other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Prostate-Specific Anti-
4
gen Screening for High-risk Insured Men Act’’ or the
5
‘‘PSA Screening for HIM Act’’.
6
VerDate Sep 11 2014
18:31 Mar 13, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H1176.IH
H1176
khammond on DSKJM1Z7X2PROD with BILLS
2
•HR 1176 IH
SEC. 2. FINDINGS.
1
Congress finds the following:
2
(1) Prostate cancer is the second leading cause
3
of cancer death in men in the United States with 1
4
in 41 men dying from prostate cancer and more
5
than 31,600 men estimated to die from prostate
6
cancer in 2019.
7
(2) Prostate cancer is the second most com-
8
monly diagnosed cancer in the Nation with 1 in 9
9
men being diagnosed in their lifetimes, 3.1 million
10
men in the United States living with a diagnosis,
11
and over 174,000 men estimated to be diagnosed in
12
2019.
13
(3) The survival rate for prostate cancer diag-
14
nosed in early stage is near 100 percent but prostate
15
cancer diagnosed in late stage has only a 30-percent
16
survival rate.
17
(4) There are few, if any, symptoms of prostate
18
cancer before it reaches late stage.
19
(5) African-American men have a disproportion-
20
ately higher rate of prostate cancer and are 70 per-
21
cent more likely to be diagnosed with prostate can-
22
cer than White men, with 1 in 6 African-American
23
men developing prostate cancer in their lifetimes.
24
(6) African-American men are 2.3 times more
25
likely to die from prostate cancer than White men.
26
VerDate Sep 11 2014
18:31 Mar 13, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H1176.IH
H1176
khammond on DSKJM1Z7X2PROD with BILLS
3
•HR 1176 IH
(7) Men with a father or brother with prostate
1
cancer are more than twice as likely to be diagnosed
2
with prostate cancer than men without a family his-
3
tory.
4
(8) The common clinical definition for men at
5
high-risk of prostate cancer includes African-Amer-
6
ican men and men with a family history.
7
(9) Most of the major cancer and urological so-
8
cieties recommend beginning screening discussions
9
earlier for African-American men and those with a
10
family history of prostate cancer.
11
(10) The United States Preventive Services
12
Task Force has encouraged research on screening
13
African-American men, including whether to screen
14
African-American men at younger ages, and has
15
identified this research as a high-priority cancer re-
16
search gap.
17
(11) Barriers to screening should be minimized
18
for high-risk men in order to catch asymptomatic
19
prostate cancer before it metastasizes and the sur-
20
vival rate is dramatically reduced.
21
(12) The cost of treating metastatic prostate
22
cancer in the United States health care system is
23
hundreds of millions of dollars more annually than
24
the cost of treating localized, early-stage cancer.
25
VerDate Sep 11 2014
18:31 Mar 13, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H1176.IH
H1176
khammond on DSKJM1Z7X2PROD with BILLS
4
•HR 1176 IH
SEC. 3. REQUIREMENT FOR GROUP HEALTH PLANS AND
1
HEALTH
INSURANCE
ISSUERS
OFFERING
2
GROUP OR INDIVIDUAL HEALTH INSURANCE
3
COVERAGE TO PROVIDE COVERAGE FOR
4
PROSTATE CANCER SCREENINGS WITHOUT
5
IMPOSITION
OF
COST-SHARING
REQUIRE-
6
MENTS.
7
(a) IN GENERAL.—Subsection (a) of section 2713 of
8
the Public Health Service Act (42 U.S.C. 300gg–13) is
9
amended to read as follows:
10
‘‘(a) COVERAGE
OF PREVENTIVE HEALTH SERV-
11
ICES.—
12
‘‘(1) IN GENERAL.—A group health plan and a
13
health insurance issuer offering group or individual
14
health insurance coverage shall, at a minimum, pro-
15
vide coverage for and shall not impose any cost-shar-
16
ing requirements for—
17
‘‘(A) evidence-based items or services that
18
have in effect a rating of ‘A’ or ‘B’ in the cur-
19
rent recommendations of the United States Pre-
20
ventive Services Task Force;
21
‘‘(B) immunizations that have in effect a
22
recommendation from the Advisory Committee
23
on Immunization Practices of the Centers for
24
Disease Control and Prevention with respect to
25
the individual involved;
26
VerDate Sep 11 2014
18:31 Mar 13, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H1176.IH
H1176
khammond on DSKJM1Z7X2PROD with BILLS
5
•HR 1176 IH
‘‘(C) with respect to infants, children, and
1
adolescents, evidence-informed preventive care
2
and screenings provided for in the comprehen-
3
sive guidelines supported by the Health Re-
4
sources and Services Administration;
5
‘‘(D) with respect to women, such addi-
6
tional preventive care and screenings not de-
7
scribed in subparagraph (A) as provided for in
8
comprehensive guidelines supported by the
9
Health Resources and Services Administration
10
for purposes of this subparagraph; and
11
‘‘(E) with respect to men who are at high
12
risk of developing prostate cancer (including Af-
13
rican-American men and men with a family his-
14
tory of prostate cancer (as defined in paragraph
15
(2))), such additional preventive care and
16
screenings not described in subparagraph (A)
17
for prostate cancer.
18
‘‘(2) MEN WITH A FAMILY HISTORY OF PROS-
19
TATE
CANCER
DEFINED.—For purposes of para-
20
graph (1)(E), the term ‘men with a family history
21
of prostate cancer’ means men who have a first-de-
22
gree relative—
23
‘‘(A) who was diagnosed with metastatic
24
prostate cancer;
25
VerDate Sep 11 2014
18:31 Mar 13, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H1176.IH
H1176
khammond on DSKJM1Z7X2PROD with BILLS
6
•HR 1176 IH
‘‘(B) who developed metastatic prostate
1
cancer; or
2
‘‘(C) whose death was a result of prostate
3
cancer.
4
‘‘(3) CLARIFICATION REGARDING BREAST CAN-
5
CER SCREENING, MAMMOGRAPHY, AND PREVENTION
6
RECOMMENDATIONS.—For the purposes of this Act,
7
and for the purposes of any other provision of law,
8
the current recommendations of the United States
9
Preventive Service Task Force regarding breast can-
10
cer screening, mammography, and prevention shall
11
be considered the most current other than those
12
issued in or around November 2009.
13
‘‘(4) RULE
OF
CONSTRUCTION.—Nothing in
14
this subsection shall be construed to prohibit a plan
15
or issuer from providing coverage for services in ad-
16
dition to those recommended by the United States
17
Preventive Services Task Force or to deny coverage
18
for services that are not recommended by such Task
19
Force.’’.
20
(b) EFFECTIVE DATE.—The amendment made by
21
subsection (a) shall apply with respect to plan years begin-
22
ning on or after January 1, 2022.
23
Æ
VerDate Sep 11 2014
18:31 Mar 13, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H1176.IH
H1176
khammond on DSKJM1Z7X2PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.